iA Global Asset Management »

Biomarin Pharmaceutical shares owned by iA Global Asset Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by iA Global Asset Management from 13F filings

Historical chart of iA Global Asset Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by iA Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by iA Global Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 16M 0.96
2024-03-31 $16M 16M 0.99
2023-12-31 $15M 15M 1.03
2023-09-30 $15M 15M 1.00

More positions owned by iA Global Asset Management

Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
UnitedHealth (UNH)
Mastercard Cl A (MA)
S&p Global (SPGI)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Linde SHS (LIN)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Visa Com Cl A (V)

View all positions for iA Global Asset Management

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Wellesley Investment Advisors
Lazard Asset Management
Victory Capital Management
iA Global Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
State Street Corporation
Jpmorgan Chase & Co
Schroder Investment Management Group
Shenkman Capital Management
Morgan Stanley
Sonora Investment Management Group
Leucadia National Corporation
Bank of America Corporation
Invesco

View all funds holding Biomarin Pharmaceutical